Effective vaccines are available against the ACWY groups (MenACWY), alongside separate MenB vaccines. However, despite successful vaccination programmes in some countries, uptake is patchy ...
The FDA approved GSK's Penmenvy vaccine for ages 10-25 ... have issued recommendations. Although MenB is the leading cause of IMD among this population, less than 13% receive the recommended ...
In most cases, childhood vaccinations would have included a meningitis vaccine that protected against MenACWY, but not MenB. Call the Student Health & Wellness Centre at 902-494-2171 to book vaccine ...
GSK’s chief scientific officer, Tony Wood, said that the results show the vaccine protects against “the broadest panel of circulating MenB strains to date,” adding that MenB is “the most ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results